Skip Navigation

European Heart Journal 2004 25(11):895-897; doi:10.1016/j.ehj.2004.04.004
Copyright © 2004 by the European Society of Cardiology.
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in EHJ
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (11)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Colombo, A.
Right arrow Articles by Iakovou, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Colombo, A.
Right arrow Articles by Iakovou, I.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Editorial

Drug-eluting stents: the new gold standard for percutaneous coronary revascularisation

Antonio Colomboa,b,* and Ioannis Iakovoub

a EMO, Centro Cuore Columbus, Via M. Buonarroti 48, 20145 Milan, Italy
b San Raffaele Hospital, Milan, Italy

* Corresponding author. Dr. Antonio Colombo
E-mail address: info@emocolumbus.it

The first 150 words of the full text of this article appear below.

This editorial refers to "Drug-eluting stents: an early systematic review to inform policy"1 by R. Hill et al. on page 902

In this comprehensive review and meta-analysis of studies performed with drug-eluting stents (DES) Hill and co-workers1 give a complete and detailed overview of this entire field. One very important element of this study is that the authors provide a large amount of data regarding studies yet to be published thus giving the reader access to a body of information not readily available.

Before entering into any more detail, two important considerations need to be made. Firstly, while sirolimus-eluting stents represent a homogeneous group utilising one single device (CypherTM, Cordis J&J, NJ), paclitaxel-eluting stents represent a variety of devices: both non-polymer based and polymer based (plastic acrylic eluting a derivative of paclitaxel and polymer eluting paclitaxel). It is therefore relatively easy to put the results of the first group . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in EHJ:

Drug-eluting stents: an early systematic review to inform policy
Ruaraidh A. Hill, Yenal Dündar, Ameet Bakhai, Rumona Dickson, and Tom Walley
EHJ 2004 25: 902-919. [Abstract] [FREE Full Text]  



This article has been cited by other articles:


Home page
 Br J AnaesthHome page
G. M. Howard-Alpe, J. de Bono, L. Hudsmith, W. P. Orr, P. Foex, and J. W. Sear
Coronary artery stents and non-cardiac surgery
Br. J. Anaesth., May 1, 2007; 98(5): 560 - 574.
[Abstract] [Full Text] [PDF]

Home page
 BMJHome page
A H Gershlick and G Richardson
Drug eluting stents
BMJ, December 16, 2006; 333(7581): 1233 - 1234.
[Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
I. Iakovou, L. Ge, and A. Colombo
Contemporary Stent Treatment of Coronary Bifurcations
J. Am. Coll. Cardiol., October 18, 2005; 46(8): 1446 - 1455.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
I. Iakovou, T. Schmidt, E. Bonizzoni, L. Ge, G. M. Sangiorgi, G. Stankovic, F. Airoldi, A. Chieffo, M. Montorfano, M. Carlino, et al.
Incidence, Predictors, and Outcome of Thrombosis After Successful Implantation of Drug-Eluting Stents
JAMA, May 4, 2005; 293(17): 2126 - 2130.
[Abstract] [Full Text] [PDF]